Chronic Disease
Chronic Disease
Modeling Health
Approximately half of all U.S. adults suffer from at least one chronic condition. Schaeffer Scholars are modeling the value of treatments and interventions that will reduce this burden.
Related Topics
Top Stories View All
News
GLP-1 Prescriptions for New Mothers Have Increased Sharply
Featured Experts: Sih-Ting Cai
In The News View All
STAT News
Kanter’s research finds patient reps on FDA advisory committees often have ties to pharma-funded groups
Featured Experts: Genevieve P. Kanter
CalMatters
Ward discusses tension between GLP-1 long-term savings and near-term insurer costs
Featured Experts: Alison Sexton Ward
CalMatters
Lin discusses why dialysis care is so expensive for privately insured patients
Featured Experts: Eugene Lin
Medscape
Peters interviewed about how new GLP-1 guidelines and price reductions will affect patients
Featured Experts: Anne Peters
NPR
Joyce interviewed about White House deal lowering prices on anti-obesity medications
Featured Experts: Geoffrey Joyce
Featured Testimony
Testimony on Incentivizing Chronic Disease Prevention and Treatment
Rebalancing the healthcare system to favor prevention and cures can potentially reduce the long-term burden of chronic diseases.
Experts: Anne Peters
Featured Article
The Economic Case for Public Investment in Stem Cell Research
Our analysis shows the measure resulted in over 56,000 jobs created and added approximately $10 billion to the state’s economy.
Experts: Dana Goldman, Bryan Tysinger
